Lexeo Therapeutics to Participate in the Leerink Global Healthcare Conference

Rhea-AI Summary

Lexeo Therapeutics (Nasdaq: LXEO) will participate in a fireside chat at the Leerink Global Healthcare Conference on March 10, 2026 at 10:00 a.m. ET in Miami, FL.

The presentation will be webcast live via the company's Investors & News & Events page, with a replay available on the Lexeo website after the session.

News Market Reaction – LXEO

-0.84%

1 alert

-0.84% News Effect

On the day this news was published, LXEO declined 0.84%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

Key Figures

Conference date: March 10, 2026 Conference time: 10:00 a.m. ET Webcast access: Live + replay

3 metrics

Conference date March 10, 2026 Leerink Global Healthcare Conference fireside chat

Conference time 10:00 a.m. ET Scheduled time for Leerink fireside chat

Webcast access Live + replay Available under News & Events on investor website

Market Reality Check

Price: $6.57 Vol: Volume 417,755 vs 20-day ...

low vol

$6.57 Last Close

Volume Volume 417,755 vs 20-day average 759,655 (relative volume 0.55) ahead of this conference news. low

Technical Shares at $7.13, trading above the $6.54 200-day moving average before the announcement.

Peers on Argus

Peers show mixed moves: MREO up 13.51%, OMER up 1.61%, MNPR up 0.38%, CAPR up 0....

Peers show mixed moves: MREO up 13.51%, OMER up 1.61%, MNPR up 0.38%, CAPR up 0.63%, while ALEC is down 7.17%, pointing to stock-specific rather than uniform sector drivers.

Historical Context

5 past events · Latest: Feb 05 (Neutral)

Pattern 5 events

Date	Event	Sentiment	Move	Catalyst
Feb 05	Investor conferences	Neutral	-5.2%	Announcement of management participation in two February 2026 investor conferences.
Jan 27	Leadership & partnership	Positive	+0.4%	Senior leadership appointments and update to strategic cardiac RNA partnership.
Jan 12	Clinical data update	Positive	-23.0%	Positive interim Phase I/II HEROIC-PKP2 data for LX2020 in cardiomyopathy.
Jan 08	Research collaboration	Positive	-5.5%	Collaboration with Johnson & Johnson on targeted cardiac AAV gene delivery.
Dec 22	Conference presentation	Neutral	+2.7%	Planned CEO presentation at the 44th Annual J.P. Morgan Healthcare Conference.

Pattern Detected

Recent positive and partnership/clinical news often saw negative next-day moves, while management/strategy updates had the only clearly positive reaction.

Recent Company History

Over the last few months, Lexeo’s news flow included multiple conferences, strategic updates, and clinical data. A Dec 22, 2025 J.P. Morgan conference presentation and a Feb 5, 2026 investor conference announcement bracketed more material items, such as a Jan 8, 2026 research collaboration with Johnson & Johnson and Jan 12, 2026 positive interim Phase I/II data for LX2020. Leadership and partnership updates on Jan 27, 2026 drew the only clearly positive price reaction, while clinical and collaboration news saw selling pressure afterward.

Regulatory & Risk Context

Active S-3 Shelf · $10 million

Shelf Active

Active S-3 Shelf Registration 2025-11-05

$10 million registered capacity

An effective shelf framework covers the resale of up to 1,250,015 shares issuable upon exercise of pre-funded warrants. Lexeo is not selling shares in this registration and would only receive nominal cash equal to the $0.0001 per-share exercise price if exercised for cash; warrants were originally sold at $7.9999 each for aggregate proceeds of approximately $10 million.

Market Pulse Summary

This announcement highlights Lexeo’s plan to present a fireside chat at the Leerink Global Healthcar...

Analysis

This announcement highlights Lexeo’s plan to present a fireside chat at the Leerink Global Healthcare Conference on March 10, 2026 at 10:00 a.m. ET, with live and replay webcasts available to investors. It continues a pattern of active conference participation following recent collaboration, clinical, and leadership news. Investors monitoring the story may focus on any incremental disclosures from the session, the company’s existing pre-funded warrant resale registration, and how these communication efforts fit alongside its broader cardiovascular gene therapy pipeline progress.

AI-generated analysis. Not financial advice.

NEW YORK, March 03, 2026 (GLOBE NEWSWIRE) -- Lexeo Therapeutics, Inc. (Nasdaq: LXEO), a clinical stage genetic medicine company dedicated to pioneering novel treatments for cardiovascular diseases, today announced that the Company will participate in a fireside chat at the Leerink Global Healthcare Conference on Tuesday, March 10, 2026 at 10:00 a.m. ET in Miami, FL.

The event will be webcast live under the News & Events tab in the Investors section of the Company’s website. A replay of the webcast will be available on the Lexeo website following the presentation.

About Lexeo Therapeutics
Lexeo Therapeutics is a New York City-based, clinical stage genetic medicine company dedicated to reshaping heart health by applying pioneering science to fundamentally change how cardiovascular diseases are treated. The company is advancing a portfolio of therapeutic candidates that take aim at the underlying genetic causes of conditions, including LX2006 in Friedreich ataxia (FA) cardiomyopathy, LX2020 in plakophilin-2 (PKP2) arrhythmogenic cardiomyopathy, and others in devastating diseases with high unmet need.

Media Response:
Media@lexeotx.com

Investor Response:
Ashley Kaplowitz
akaplowitz@lexeotx.com

FAQ

When will Lexeo Therapeutics (LXEO) present at the Leerink Global Healthcare Conference?

Lexeo will present on March 10, 2026 at 10:00 a.m. ET in Miami. According to Lexeo, the presentation is a scheduled fireside chat and is part of the conference agenda with a live webcast for remote viewers.

How can investors watch the Lexeo (LXEO) fireside chat on March 10, 2026?

Investors can watch via a live webcast on the company's Investors & News & Events page. According to Lexeo, the webcast will stream live and a replay will be posted on the Lexeo website after the presentation for later viewing.

Will Lexeo (LXEO) make the March 10, 2026 presentation available after the Leerink conference?

Yes, a replay will be available on the Lexeo website following the presentation. According to Lexeo, the company will post the session replay under its News & Events tab in the Investors section.

What is the format of Lexeo's (LXEO) session at the Leerink Global Healthcare Conference?

The session is a fireside chat, typically an interviewer-led discussion focused on company developments. According to Lexeo, the format will include discussion of recent progress and will be accessible live via webcast for investors.

Where will the Lexeo (LXEO) Leerink conference presentation take place and who should attend?

The presentation takes place in Miami, FL on March 10, 2026 and is aimed at investors and industry participants. According to Lexeo, the event will also be webcast for remote investors who cannot attend in person.